A Phase Ib/IIa Trial of the Combination of Romidepsin, Lenalidomide and Carfilzomib in Patients with Relapsed/Refractory Lymphoma Shows Complete Responses in Relapsed and Refractory B-and T-Cell Lymphomas

被引：0
|
作者：
Mehta-Shah, Neha
Moskowitz, Alison J.
Lunning, Matthew A.
Lynch, Peggy
Scheuerman, Mark
Minnal, Veenna
Galasso, Natasha
Kumar, Anita
Gerecitano, John
Zelenetz, Andrew D.
Hamlin, Paul A.
Noy, Ariela
Matasar, Matthew J.
Palomba, Maria Lia
Younes, Anas
Schaffer, Wendy
Grewal, Ravinder
Rademaker, Jurgen
Sauter, Craig S.
Dahi, Parastoo B.
Myskowski, Patricia
Kheterpal, Meenal
Dogan, Ahmet
Pulitzer, Melissa
Lubin, Lakeisha
Tang, Laura
Ganesan, Nivetha
Ni, Ai
Horwitz, Steven M.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
821
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Combination of Lenalidomide and Rituximab in Elderly Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Phase 2 Trial
    Zinzani, Pier Luigi
    Pellegrini, Cinzia
    Gandolfi, Letizia
    Stefoni, Vittorio
    Quirini, Federica
    Derenzini, Enrico
    Broccoli, Alessandro
    Argnani, Lisa
    Pileri, Stefano
    Baccarani, Michele
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (06): : 462 - 466
  • [32] Combination of Mitoxantrone Hydrochloride Liposome with Tislelizumab in Patients with Relapsed or Refractory NK/T Cell Lymphoma: A Phase Ib/. Clinical Trial
    Cai, Qingqing
    Xia, Yi
    Wang, Liang
    Huang, Huiqiang
    Wang, Jinni
    Cai, Jun
    Tian, Xiaopeng
    BLOOD, 2023, 142
  • [33] The Pralatrexate - Romidepsin Doublet: A Well Tolerated and Highly Effective Combination for Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
    Amengual, Jennifer E.
    Lichtenstein, Renee
    Rojas, Celeste
    Sawas, Ahmed
    Deng, Changchun
    Lichtenstien, Emily
    Kahn, Karen
    Lue, Jennifer Kimberly
    Liu, Yuxuan
    Qiao, Changhong
    Nandakumar, Renu
    Cremers, Serge
    O'Connor, Owen A.
    BLOOD, 2016, 128 (22)
  • [34] A phase I study of carfilzomib in combination with ibrutinib for relapsed refractory mantle cell lymphoma
    Lee, Hun J.
    Schmelz, Jacob L.
    Cramer, Fred
    Romaguera, Jorge E.
    Badillo, Maria
    Wang, Michael
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (06) : E94 - E98
  • [35] A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma
    Amengual, Jennifer E.
    Lichtenstein, Renee
    Lue, Jennifer
    Sawas, Ahmed
    Deng, Changchun
    Lichtenstein, Emily
    Khan, Karen
    Atkins, Laine
    Rada, Aishling
    Kim, Hye A.
    Chiuzan, Codruta
    Kalac, Matko
    Marchi, Enrica
    Falchi, Lorenzo
    Francescone, Mark A.
    Schwartz, Lawrence
    Cremers, Serge
    O'Connor, Owen A.
    BLOOD, 2018, 131 (04) : 397 - 407
  • [36] Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified
    Zinzani, Pier Luigi
    Pellegrini, Cinzia
    Broccoli, Alessandro
    Stefoni, Vittorio
    Gandolfi, Letizia
    Quirini, Federica
    Argnani, Lisa
    Berti, Emilio
    Derenzini, Enrico
    Pileri, Stefano
    Baccarani, Michele
    LEUKEMIA & LYMPHOMA, 2011, 52 (08) : 1585 - 1588
  • [37] A Phase I Trial of Brentuximab Vedotin in Combination with Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Ward, Jeffrey P.
    Thein, Jessica
    Luo, Jingqin
    Wagner-Johnston, Nina D.
    Cashen, Amanda F.
    Fehniger, Todd A.
    Bartlett, Nancy L.
    BLOOD, 2015, 126 (23)
  • [38] A Phase I Study of Nivolumab and Lenalidomide in Relapsed/ Refractory B Cell Lymphoma
    Bond, David A.
    Yildiz, Vedat
    Wei, Lai
    Alinari, Lapo
    William, Basem M.
    Brammer, Jonathan E.
    Christian, Beth A.
    Blum, Kristie A.
    Maddocks, Kami J.
    BLOOD, 2019, 134
  • [39] Romidepsin in relapsed/refractory T-cell lymphomas: Italian experience and results of a named patient program
    Zinzani, Pier Luigi
    Pellegrini, Cinzia
    Cerciello, Giuseppe
    Monaco, Federico
    Volpetti, Stefano
    Peli, Annalisa
    Angelucci, Emanuele
    Corradini, Paolo
    Cox, Maria Christina
    Guarini, Attilio
    Musso, Maurizio
    Bresciani, Paola
    Amato, Gabriella
    Billio, Atto
    Caparrotti, Giuseppe
    Figuera, Amalia
    Nassi, Luca
    Gaudio, Francesco
    Grossi, Alberto
    Onida, Francesco
    Merli, Michele
    Rigacci, Luigi
    Argnani, Lisa
    LEUKEMIA & LYMPHOMA, 2016, 57 (10) : 2370 - 2374
  • [40] Phase I/II Clinical Trial of Temsirolimus and Lenalidomide in Patients with Relapsed and Refractory Lymphomas
    Major, Ajay
    Kline, Justin
    Karrison, Theodore G.
    Fishkin, Paul A. S.
    Kimball, Amy S.
    Petrich, Adam M.
    Nattam, Sreenivasa
    Sleckman, Bethany G.
    Cohen, Kenneth
    van Besien, Koen
    Rapoport, Aaron P.
    Smith, Sonali M.
    BLOOD, 2020, 136
12345